Hence, extreme caution would be required to select patients who could benefit from apelin as a therapeutic agent because our results strongly suggest that either obesity‐related levels of apelin as well as apelin infusion is able to increase TNBC growth and seeding to peripheric tissues, like the brain. This evidence concerns the gene APLN and obesity due to melanocortin 4 receptor deficiency.